Q1 2022 Holdings
Filed 2022-05-16 | 27 holdings | $126.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $39.9M | 2,314,648 | 31.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $31.5M | 854,652 | 24.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $26.2M | 3,500,768 | 20.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $11.7M | 481,094 | 9.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $8.6M | 920,464 | 6.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.2M | 241,199 | 6.5% |
| Merus N V | COM | N5749R100 | $48.0K | 1,816,421 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $38.8K | 5,637,630 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $37.3K | 2,214,961 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $36.8K | 1,202,613 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $26.2K | 3,561,052 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $17.8K | 5,738,500 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $17.6K | 951,339 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $14.3K | 1,744,570 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $14.1K | 3,711,286 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $12.5K | 10,097,229 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $12.5K | 776,514 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $10.1K | 893,013 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.9K | 331,886 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $6.1K | 513,930 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.6K | 312,553 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $3.9K | 3,079,756 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.0K | 262,658 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.9K | 305,125 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $2.6K | 125,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $2.5K | 250,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $2.2K | 1,954,970 | 0.0% |